Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$5.3 - $6.91 $66,456 - $86,644
-12,539 Reduced 14.48%
74,062 $413,000
Q1 2024

May 03, 2024

BUY
$6.29 - $9.15 $10,705 - $15,573
1,702 Added 2.0%
86,601 $581,000
Q4 2023

Feb 08, 2024

BUY
$4.1 - $9.51 $1,553 - $3,604
379 Added 0.45%
84,899 $774,000
Q3 2023

Nov 09, 2023

BUY
$5.52 - $9.5 $77,567 - $133,494
14,052 Added 19.94%
84,520 $466,000
Q2 2023

Aug 07, 2023

BUY
$6.69 - $11.99 $471,430 - $844,911
70,468 New
70,468 $601,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $874M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.